| |
| |
|
| Insider
Information: |
Kulkarni Samarth |
| Relationship: |
|
| City: |
Cambridge |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
208,122 |
|
|
Indirect Shares
|
200,000 |
|
|
| Direct
Value |
$11,207,370 |
|
|
|
Indirect Value
|
$10,770,000 |
|
|
| Total
Shares |
408,122 |
|
|
| Total
Value |
$21,977,370 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
3
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
3
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
-3.0
|
| Percentage
Gain/Loss : |
0.0%
|
 -82.7%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Crispr Therapeutics Ag |
CRSP |
|
2024-04-15 |
208,122 |
2024-04-15 |
200,000 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
113 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 5
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| CRSP |
Crispr Therapeutics Ag |
Chief Business OfficerOfficer |
• – – |
2016-10-18 |
3 |
IO |
$0.00 |
$0 |
D/D |
0 |
134,047 |
|
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2019-09-01 |
4 |
D |
$46.21 |
$34,195 |
D/D |
(740) |
165,061 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2018-06-04 |
4 |
D |
$67.13 |
$49,743 |
D/D |
(741) |
147,819 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2018-09-01 |
4 |
D |
$56.67 |
$41,992 |
D/D |
(741) |
146,531 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2018-12-01 |
4 |
D |
$38.33 |
$28,403 |
D/D |
(741) |
145,790 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2019-06-01 |
4 |
D |
$35.57 |
$26,357 |
D/D |
(741) |
165,801 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2019-12-01 |
4 |
D |
$71.65 |
$53,093 |
D/D |
(741) |
164,320 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2019-03-01 |
4 |
D |
$39.97 |
$29,898 |
D/D |
(748) |
166,542 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2020-06-02 |
4 |
D |
$66.26 |
$51,617 |
D/D |
(779) |
170,747 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2020-09-02 |
4 |
D |
$94.15 |
$73,343 |
D/D |
(779) |
169,968 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2020-12-01 |
4 |
D |
$129.58 |
$100,943 |
D/D |
(779) |
169,189 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2021-06-01 |
4 |
D |
$115.80 |
$90,208 |
D/D |
(779) |
187,719 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2021-12-01 |
4 |
D |
$75.10 |
$58,503 |
D/D |
(779) |
219,153 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2021-09-01 |
4 |
D |
$124.83 |
$98,241 |
D/D |
(787) |
186,932 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2020-03-02 |
4 |
D |
$52.74 |
$41,876 |
D/D |
(794) |
171,526 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2021-03-01 |
4 |
D |
$130.25 |
$103,940 |
D/D |
(798) |
182,191 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2021-08-04 |
4 |
OE |
$12.57 |
$18,855 |
D/D |
1,500 |
189,219 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Executive Officer |
• • – |
2021-08-04 |
4 |
AS |
$125.02 |
$187,530 |
D/D |
(1,500) |
187,719 |
0 |
% |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Business Officer |
• – – |
2017-04-27 |
4 |
OE |
$1.81 |
$3,993 |
D/D |
2,206 |
136,253 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Business Officer |
• – – |
2017-04-27 |
4 |
AS |
$16.78 |
$37,023 |
D/D |
(2,206) |
134,047 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Business Officer |
• – – |
2017-04-20 |
4 |
AS |
$17.36 |
$48,621 |
D/D |
(2,800) |
134,047 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Business Officer |
• – – |
2017-04-20 |
4 |
OE |
$1.81 |
$5,068 |
D/D |
2,800 |
136,847 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Business Officer |
• – – |
2017-04-21 |
4 |
AS |
$17.01 |
$51,033 |
D/D |
(3,000) |
134,047 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Business Officer |
• – – |
2017-04-21 |
4 |
OE |
$1.81 |
$5,430 |
D/D |
3,000 |
137,047 |
0 |
- |
|
| CRSP |
Crispr Therapeutics Ag |
Chief Business Officer |
• – – |
2017-04-26 |
4 |
AS |
$16.74 |
$54,816 |
D/D |
(3,275) |
134,047 |
0 |
- |
|
113 Records found
|
|
Page 1 of 5 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
